Literature DB >> 18197800

Fungal capsular polysaccharide and T-cell suppression: the hidden nature of poor immunogenicity.

Anna Vecchiarelli1.   

Abstract

Many capsular polysaccharide antigens are generally considered to be classic T-cell independent antigens that stimulate humoral response. This response is poor and short lived due to the absence of T-cell involvement. Recent emerging evidence suggests that fungal capsular polysaccharides may negatively affect T-cell response. This effect is indirectly mediated by antigen-presenting cells that sense microbial polysaccharides and manage T-cell response. This review will revisit the role of the cryptococcal capsular polysaccharide as a nonconventional regulator of natural and adaptive immune response, revealing the hidden nature of its poor immunogenicity and novel opportunities for the biomedical exploitation of this nontoxic compound.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18197800     DOI: 10.1615/critrevimmunol.v27.i6.50

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  14 in total

1.  Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter.

Authors:  Fernanda L Fonseca; Lilian L Nohara; Radames J B Cordero; Susana Frases; Arturo Casadevall; Igor C Almeida; Leonardo Nimrichter; Marcio L Rodrigues
Journal:  Infect Immun       Date:  2010-06-14       Impact factor: 3.441

2.  A critical role for FcgammaRIIB in up-regulation of Fas ligand induced by a microbial polysaccharide.

Authors:  M Piccioni; C Monari; S Bevilacqua; S Perito; F Bistoni; T R Kozel; A Vecchiarelli
Journal:  Clin Exp Immunol       Date:  2011-05-23       Impact factor: 4.330

Review 3.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2011-03-11       Impact factor: 53.106

4.  A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock.

Authors:  M Piccioni; C Monari; S Kenno; E Pericolini; E Gabrielli; D Pietrella; S Perito; F Bistoni; T R Kozel; A Vecchiarelli
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

5.  Fungal cell gigantism during mammalian infection.

Authors:  Oscar Zaragoza; Rocío García-Rodas; Joshua D Nosanchuk; Manuel Cuenca-Estrella; Juan Luis Rodríguez-Tudela; Arturo Casadevall
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

6.  Structural and functional properties of the Trichosporon asahii glucuronoxylomannan.

Authors:  Fernanda L Fonseca; Susana Frases; Arturo Casadevall; Olga Fischman-Gompertz; Leonardo Nimrichter; Marcio L Rodrigues
Journal:  Fungal Genet Biol       Date:  2009-03-12       Impact factor: 3.495

7.  Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.

Authors:  Allan Jefferson Guimarães; Susana Frases; Radamés J B Cordero; Leonardo Nimrichter; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Cell Microbiol       Date:  2010-01-11       Impact factor: 3.715

8.  Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan.

Authors:  Débora L Oliveira; Leonardo Nimrichter; Kildare Miranda; Susana Frases; Kym F Faull; Arturo Casadevall; Marcio L Rodrigues
Journal:  Fungal Genet Biol       Date:  2009-09-10       Impact factor: 3.495

9.  The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.

Authors:  Antonio Nakouzi; Tong Zhang; Stefan Oscarson; Arturo Casadevall
Journal:  Vaccine       Date:  2009-04-19       Impact factor: 3.641

10.  The presence of capsule in Cryptococcus neoformans influences the gene expression profile in dendritic cells during interaction with the fungus.

Authors:  P Lupo; Y C Chang; B L Kelsall; J M Farber; D Pietrella; A Vecchiarelli; F Leon; K J Kwon-Chung
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.